G0800318/MRC_/Medical Research Council/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	1
2009	1
2011	2
2012	5
2013	4
2014	1
2015	4
2016	7
2017	4
2019	1
2024	0

1

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.

Thompson AAR, Lawrie A. Thompson AAR, et al. Trends Mol Med. 2017 Jan;23(1):31-45. doi: 10.1016/j.molmed.2016.11.005. Epub 2016 Dec 16. Trends Mol Med. 2017. PMID: 27989641 Free article. Review.

2

Osteoprotegerin in Cardiometabolic Disorders.

Pérez de Ciriza C, Lawrie A, Varo N. Pérez de Ciriza C, et al. Int J Endocrinol. 2015;2015:564934. doi: 10.1155/2015/564934. Epub 2015 May 11. Int J Endocrinol. 2015. PMID: 26078757 Free PMC article. Review.

3

A report on the use of animal models and phenotyping methods in pulmonary hypertension research.

Lawrie A. Lawrie A. Pulm Circ. 2014 Mar;4(1):2-9. doi: 10.1086/674886. Pulm Circ. 2014. PMID: 25006416 Free PMC article. Review.

4

From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease.

Dawson S, Lawrie A. Dawson S, et al. Pharmacol Ther. 2017 Jan;169:78-82. doi: 10.1016/j.pharmthera.2016.06.017. Epub 2016 Jul 1. Pharmacol Ther. 2017. PMID: 27373854 Free PMC article. Review.

5

miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?

Rothman AM, Rowlands DJ, Lawrie A. Rothman AM, et al. Epigenomics. 2016 Oct;8(10):1311-1313. doi: 10.2217/epi-2016-0089. Epub 2016 Sep 7. Epigenomics. 2016. PMID: 27600267 Free article. No abstract available.

6

MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.

Rothman AM, Arnold ND, Pickworth JA, Iremonger J, Ciuclan L, Allen RM, Guth-Gundel S, Southwood M, Morrell NW, Thomas M, Francis SE, Rowlands DJ, Lawrie A. Rothman AM, et al. J Clin Invest. 2016 Jul 1;126(7):2495-508. doi: 10.1172/JCI83361. Epub 2016 May 23. J Clin Invest. 2016. PMID: 27214554 Free PMC article.

7

Maintained right ventricular pressure overload induces ventricular-arterial decoupling in mice.

Boehm M, Lawrie A, Wilhelm J, Ghofrani HA, Grimminger F, Weissmann N, Seeger W, Schermuly RT, Kojonazarov B. Boehm M, et al. Exp Physiol. 2017 Feb 1;102(2):180-189. doi: 10.1113/EP085963. Exp Physiol. 2017. PMID: 27990701 Free article.

8

Pulmonary hypertension in COPD: results from the ASPIRE registry.

Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C, Pollard L, Wild JM, Lawrie A, Lawson R, Sabroe I, Kiely DG. Hurdman J, et al. Eur Respir J. 2013 Jun;41(6):1292-301. doi: 10.1183/09031936.00079512. Epub 2012 Sep 27. Eur Respir J. 2013. PMID: 23018917 Free article.

9

Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension.

Lawrie A, Waterman E, Southwood M, Evans D, Suntharalingam J, Francis S, Crossman D, Croucher P, Morrell N, Newman C. Lawrie A, et al. Am J Pathol. 2008 Jan;172(1):256-64. doi: 10.2353/ajpath.2008.070395. Epub 2007 Dec 21. Am J Pathol. 2008. PMID: 18156213 Free PMC article.

10

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

Rhodes CJ, Wharton J, Boon RA, Roexe T, Tsang H, Wojciak-Stothard B, Chakrabarti A, Howard LS, Gibbs JS, Lawrie A, Condliffe R, Elliot CA, Kiely DG, Huson L, Ghofrani HA, Tiede H, Schermuly R, Zeiher AM, Dimmeler S, Wilkins MR. Rhodes CJ, et al. Am J Respir Crit Care Med. 2013 Feb 1;187(3):294-302. doi: 10.1164/rccm.201205-0839OC. Epub 2012 Dec 6. Am J Respir Crit Care Med. 2013. PMID: 23220912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year